Overview
- 21Shares submitted its spot Injective (INJ) ETF proposal to the U.S. Securities and Exchange Commission on October 20, 2025.
- The proposed fund seeks to provide direct price exposure by holding INJ tokens in cold storage custody.
- Injective’s official X account shared the filing, elevating visibility and investor attention to the application.
- INJ now has multiple ETF proposals in progress, with earlier filings from Canary Capital and Rex Osprey also before the SEC.
- Market reaction was measured, with INJ trading near $8.75 and 24-hour volume around $79.4 million as staking participation continued to rise.